In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management Hallie A. CarolElisa N. OchfeldAisha Ahmed Letter to the Editor 03 June 2022 Pages: 561 - 565
Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis Han-qi ZhangSi-Wei YangMing-Yi Zhao Review 11 July 2022 Pages: 566 - 577
Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation Naveen ChallagundlaBhaskar SahaReena Agrawal-Rajput Review 24 May 2022 Pages: 578 - 606
Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors Sumra KomalNimrah KomalSheng-Na Han Review 24 May 2022 Pages: 607 - 623
Livin promotes Th2-type immune response in airway allergic diseases Yue WangZhiyu XiangPingchang Yang Original Article Open access 18 June 2022 Pages: 624 - 632
High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice Devlina GhoshAditi SinghNeeraj Sinha Original Article 07 June 2022 Pages: 633 - 643
Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis Raouia FakhfakhZeineb ZianHatem Masmoudi Original Article 06 June 2022 Pages: 644 - 653
Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet’s disease Nilgun SallakciIlhan TahraliGunnur Deniz Original Article 03 June 2022 Pages: 654 - 666
The ability of inflammatory markers to recognize infection in cancer patients with fever at admission Lubei RaoKaijiong ZhangDongsheng Wang Original Article 28 June 2022 Pages: 667 - 677
Hydroquinone predisposes for retinal pigment epithelial (RPE) cell degeneration in inflammatory conditions Niina BhattaraiMaria HyttiAnu Kauppinen Original Article Open access 04 June 2022 Pages: 678 - 687
Tryptanthrin attenuates TLR3-mediated STAT1 activation in THP-1 cells Noriyuki NumaoShogo KawaguchiTadaatsu Imaizumi Original Article 06 June 2022 Pages: 688 - 697
Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome Marcus DerigsHendrik HeersJörg Hänze Original Article Open access 23 June 2022 Pages: 698 - 707
The alterations of cerebrospinal fluid TNF-alpha and TGF-beta2 levels in early relapsing–remitting multiple sclerosis Tomasz GrzegorskiPiotr IwanowskiJacek Losy Original Article 21 June 2022 Pages: 708 - 713
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels Anthony DobiArthur DubernetPhilippe Gasque Brief Report 09 June 2022 Pages: 714 - 719